SCHEMBL5250216

SCHEMBL5250216

C(=C/c1n[nH]c2ccccc12)\c1ccccn1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.64
NTRK1 P04629 6/20 0.57
NTRK2 Q16620 6/20 0.57
NTRK3 Q16288 5/20 0.57
KDR P35968 8/20 0.54
MEN1 O00255 1/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
KMT2A Q03164 1/20 0.53
ATM Q13315 1/20 0.53
LRRK2 Q5S007 3/20 0.50
FGFR1 P11362 6/20 0.49
CSF1R P07333 3/20 0.49
PDGFRB P09619 3/20 0.49
KIT P10721 3/20 0.49
PDGFRA P16234 3/20 0.49
LCK P06239 3/20 0.49
PLK4 O00444 2/20 0.49
AURKA O14965 2/20 0.49
MAP4K4 O95819 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29683745 1.00 CHEK1 (0.64) CHEK1NTRK1NTRK2NTRK3KDR
SCHEMBL30236917 1.00 CHEK1 (0.64) CHEK1NTRK1NTRK2NTRK3KDR
SCHEMBL5498220 0.82 KDR (0.69) CHEK1NTRK1NTRK2NTRK3KDR
SCHEMBL14539159 0.82 CHEK1 (0.67) CHEK1NTRK1NTRK2NTRK3KDR
SCHEMBL29531075 0.82 CHEK1 (0.67) CHEK1NTRK1NTRK2NTRK3KDR
SCHEMBL28884515 0.82 CHEK1 (0.67) CHEK1NTRK1NTRK2NTRK3KDR
SCHEMBL28884514 0.82 CHEK1 (0.67) CHEK1NTRK1NTRK2NTRK3KDR
SCHEMBL22099881 0.82 NTRK3 (0.60) CHEK1NTRK1NTRK2NTRK3KDR
SCHEMBL22099879 0.82 NTRK3 (0.60) CHEK1NTRK1NTRK2NTRK3KDR
SCHEMBL5498217 0.82 CHEK1 (0.67) CHEK1NTRK1NTRK2NTRK3KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1614683-B1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use AGOURON PHARMA (US) 2007-11-21 EP disclosed